Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.

Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM; Synaptic Health Endpoints Working Group.

Alzheimers Res Ther. 2020 Mar 2;12(1):21. doi: 10.1186/s13195-020-00588-4. Review.


Comparative profiling of the synaptic proteome from Alzheimer's disease patients with focus on the APOE genotype.

Hesse R, Hurtado ML, Jackson RJ, Eaton SL, Herrmann AG, Colom-Cadena M, Tzioras M, King D, Rose J, Tulloch J, McKenzie CA, Smith C, Henstridge CM, Lamont D, Wishart TM, Spires-Jones TL.

Acta Neuropathol Commun. 2019 Dec 20;7(1):214. doi: 10.1186/s40478-019-0847-7.


PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.

Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, Asfaw A, Hall TC, Ding L, DeSousa A, Frosch MP, Collinge J, Harris DA, Perkinton MS, Spires-Jones TL, Young-Pearse TL, Billinton A, Walsh DM.

Acta Neuropathol. 2020 Mar;139(3):503-526. doi: 10.1007/s00401-019-02114-9. Epub 2019 Dec 18.


Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease.

Pickett EK, Herrmann AG, McQueen J, Abt K, Dando O, Tulloch J, Jain P, Dunnett S, Sohrabi S, Fjeldstad MP, Calkin W, Murison L, Jackson RJ, Tzioras M, Stevenson A, d'Orange M, Hooley M, Davies C, Colom-Cadena M, Anton-Fernandez A, King D, Oren I, Rose J, McKenzie CA, Allison E, Smith C, Hardt O, Henstridge CM, Hardingham GE, Spires-Jones TL.

Cell Rep. 2019 Dec 10;29(11):3592-3604.e5. doi: 10.1016/j.celrep.2019.11.044.


Teaching case 3-2019: Are nuclear clefts or invaginations the niche of intranuclear inclusions in FTLD-TDP?

Molina-Porcel L, Pérez-Navarro E, García-Forn M, Westaway D, Colom-Cadena M, Gelpi E.

Clin Neuropathol. 2019 May/Jun;38(3):97-99. doi: 10.5414/NP301202. No abstract available.


Nanoscale structure of amyloid-β plaques in Alzheimer's disease.

Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, Nuñez-Llaves R, Luque-Cabecerans J, Muñoz-Llahuna L, Andilla J, Belbin O, Spires-Jones TL, Gelpi E, Clarimon J, Loza-Alvarez P, Fortea J, Lleó A.

Sci Rep. 2019 Mar 26;9(1):5181. doi: 10.1038/s41598-019-41443-3.


Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models.

Gelpi E, Colom-Cadena M.

Brain. 2019 Feb 1;142(2):228-230. doi: 10.1093/brain/awy342. No abstract available.


Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Lleó A, Núñez-Llaves R, Alcolea D, Chiva C, Balateu-Paños D, Colom-Cadena M, Gomez-Giro G, Muñoz L, Querol-Vilaseca M, Pegueroles J, Rami L, Lladó A, Molinuevo JL, Tainta M, Clarimón J, Spires-Jones T, Blesa R, Fortea J, Martínez-Lage P, Sánchez-Valle R, Sabidó E, Bayés À, Belbin O.

Mol Cell Proteomics. 2019 Mar;18(3):546-560. doi: 10.1074/mcp.RA118.001290. Epub 2019 Jan 3.


Tauopathy with Hippocampal 4-Repeat Tau Immunoreactive Spherical Inclusions in a Patient with PSP.

Borrego-Écija S, Grau-Rivera O, Colom-Cadena M, Molinuevo JL, Tolosa E, Sánchez-Valle R, Gelpi E.

Brain Pathol. 2018 Mar;28(2):284-286. doi: 10.1111/bpa.12506. No abstract available.


Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Muñoz L, Querol-Vilaseca M, Martín-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Núñez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleó A.

Brain. 2017 Dec 1;140(12):3204-3214. doi: 10.1093/brain/awx275.


YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.

Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, San Martín-Paniello C, Clarimon J, Belbin O, Fortea J, Lleó A.

J Neuroinflammation. 2017 Jun 9;14(1):118. doi: 10.1186/s12974-017-0893-7.


Regional Overlap of Pathologies in Lewy Body Disorders.

Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Muñoz L, Kulisevsky J, Martí MJ, Tolosa E, Clarimon J, Lleó A, Gelpi E.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224. doi: 10.1093/jnen/nlx002.


Conjoint FTLD-FUS of the neuronal intermediate filament inclusion disease type, progressive supranuclear palsy and Alzheimer's pathology presenting as parkinsonism with early falls and late hallucinations, psychosis and dementia.

Compta Y, Ramos-Campoy O, Grau-Rivera O, Colom-Cadena M, Clarimón J, Martí MJ, Gelpi E.

Neuropathol Appl Neurobiol. 2017 Jun;43(4):352-357. doi: 10.1111/nan.12340. No abstract available.


Non-Fibrillar Oligomeric Amyloid-β within Synapses.

Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL.

J Alzheimers Dis. 2016 May 30;53(3):787-800. doi: 10.3233/JAD-160007.


Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.

Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Martí MJ, Clarimón J, Lleó A.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1203-12. doi: 10.1097/NEN.0000000000000018.


Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.

Suárez-Calvet M, Belbin O, Pera M, Badiola N, Magrané J, Guardia-Laguarta C, Muñoz L, Colom-Cadena M, Clarimón J, Lleó A.

J Neurochem. 2014 Jan;128(2):330-9. doi: 10.1111/jnc.12466. Epub 2013 Oct 24.


Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.

Pera M, Alcolea D, Sánchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, Suárez-Calvet M, Lladó A, Barrera-Ocampo AA, Sepulveda-Falla D, Blesa R, Molinuevo JL, Clarimón J, Ferrer I, Gelpi E, Lleó A.

Acta Neuropathol. 2013 Feb;125(2):201-13. doi: 10.1007/s00401-012-1062-9. Epub 2012 Dec 6.


MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies.

Colom-Cadena M, Gelpi E, Martí MJ, Charif S, Dols-Icardo O, Blesa R, Clarimón J, Lleó A.

Neurobiol Aging. 2013 Mar;34(3):936-42. doi: 10.1016/j.neurobiolaging.2012.06.015. Epub 2012 Jul 21.


Pick's pathology in Parkinson's disease with dementia.

Vilas D, Marti MJ, Botta-Orfila T, Colom-Cadena M, Gelpi E.

Neuropathol Appl Neurobiol. 2012 Dec;38(7):737-43. doi: 10.1111/j.1365-2990.2012.01287.x. No abstract available.


Supplemental Content

Loading ...
Support Center